Endometrial Adenosquamous Carcinoma

Endometrial Adenosquamous Carcinoma, also known as adenosquamous carcinoma of the endometrium, is related to adenoid squamous cell carcinoma and endometrial adenocarcinoma. An important gene associated with Endometrial Adenosquamous Carcinoma is ARHGAP19 (Rho GTPase Activating Protein 19), and among its related pathways/superpathways are Regulation of TP53 Activity and TP53 Regulates Metabolic Genes. The drugs Cisplatin and Lenograstim have been mentioned in the context of this disorder. Affiliated tissues include endothelial and uterus.